Novo Nordisk A/S
NVO
$44.96
$0.571.28%
NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 18.81B | 15.45B | 15.30B | 16.18B | 15.05B |
| Total Depreciation and Amortization | 2.17B | 2.16B | 1.97B | 1.76B | 1.42B |
| Total Amortization of Deferred Charges | 49.57M | 49.57M | 36.44M | 36.44M | 36.44M |
| Total Other Non-Cash Items | -734.74M | -503.15M | 1.65B | 1.09B | 2.96B |
| Change in Net Operating Assets | -1.98B | 946.99M | -283.94M | -1.17B | -467.69M |
| Cash from Operations | 18.31B | 18.10B | 18.67B | 17.91B | 19.00B |
| Capital Expenditure | -8.97B | -9.13B | -8.56B | -8.21B | -7.49B |
| Sale of Property, Plant, and Equipment | -- | -- | -142.90K | 4.50K | 4.50K |
| Cash Acquisitions | 156.49M | 156.49M | -11.65B | -11.65B | -11.74B |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -4.24B | -3.13B | 1.74B | 730.00M | -717.00M |
| Cash from Investing | -13.05B | -12.10B | -18.46B | -19.13B | -19.95B |
| Total Debt Issued | 92.55B | 103.93B | 118.07B | 117.48B | 106.75B |
| Total Debt Repaid | -68.39B | -79.19B | -78.47B | -77.85B | -18.05B |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -2.40B | -1.39B | -8.88B | -11.28B | -18.73B |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -8.03B | -7.59B | -7.59B | -7.27B | -7.27B |
| Other Financing Activities | -21.25B | -833.00M | -833.00M | -833.00M | 20.62B |
| Cash from Financing | -7.79B | -4.47B | -3.79B | -3.83B | 5.61B |
| Foreign Exchange rate Adjustments | -139.20M | -108.95M | -23.01M | -84.15M | 45.12M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -2.68B | 1.43B | -3.61B | -5.13B | 4.70B |